Dana-Farber

How Does Chemotherapy Work? Including Oral Chemotherapy and Immunotherapy

by

More than half of all people with cancer will get chemotherapy – powerful drugs that kill cancer cells to cure the disease, slow its growth, or reduce its symptoms. There are more than 100 different drugs used in chemotherapy, sometimes alone, but more often in combinations that have proven effective against specific types of cancer. … Read more

What Is Merkel Cell Carcinoma?

by

Merkel cells are found just below your skin’s surface, on the lowest level of your top layer of skin (the epidermis). Connected to nerve endings associated with the sensation of pressure, Merkel cells play a key role in helping us identify fine details and textures by touch.  What is Merkel cell carcinoma?  Merkel cell carcinoma is … Read more

What is Liposarcoma?

by

Cancers known as sarcomas develop in the connective tissues, such as muscle, fat, and bone, that hold the body together. The type of sarcoma called liposarcoma originates in fat cells that have been driven by random DNA errors into malignant growth, forming tumors. George Demetri, MD, director of Dana-Farber’s Center for Sarcoma and Bone Oncology, … Read more

Dentist Brings a Smile to Transplant Patients

by

Like many family members of cancer patients, Stephen Matarazzo, DMD, wanted a meaningful way to thank the Dana-Farber caregivers who saved his son Michael’s life. What he came up with involved offering his own professional expertise to protect the smiles of others. A dentist based in Quincy, Mass., Matarazzo provides pro bono dental exams and … Read more

Five Things You Need to Know About Cancer Genetics

by

Although most cancers are sporadic or occur by chance, a small percentage are due to inherited genetic (or germline) mutations, which can often be identified through genetic testing. These mutations are different from somatic mutations, which are not inherited, but occur during one’s lifetime. Profile, a research project launched by Dana-Farber and Brigham and Women’s Hospital, … Read more

What Does No Hair Loss During Chemo Mean?

by

Medically reviewed by Clare Sullivan, BSN, MPH, CRRN It’s well known that many chemotherapy medications used to treat cancer can bring undesirable side effects, such as hair loss, lack of appetite, and fatigue. But experiencing such symptoms is not an indication of whether cancer treatment is working. How does chemotherapy affect cells? Chemotherapy interferes with … Read more

How Cancer Researchers Are Working to Help Fight MERS Virus

by

Middle East Respiratory Syndrome (MERS), a viral respiratory illness has been in the news a lot lately.  MERS, first detected in Saudia Arabia in 2012, is caused by a coronavirus called “Middle East Respiratory Syndrome Coronavirus” (MERS-CoV). It isn’t known exactly where the virus comes from though many infectious disease experts think it is likely … Read more

Play Ball: The Red Sox and Jimmy Fund Start Another Season Together

by

Their season starts today, and although the Boston Red Sox will have a lot of competition in their quest to repeat as World Series champions, fans can be certain of one thing: a continuation of the baseball team’s special bond with the Jimmy Fund and Dana-Farber Cancer Institute.

Dating from 1953, this is the longest and most successful partnership between a professional sports team and charity in North America. The Red Sox have helped the Jimmy Fund raise millions of dollars for cancer care and research at Dana-Farber through appearances and appeals while befriending patients of all ages.

Here are some highlights from the long-standing connection between these two New England institutions.

Read more

A History of Multiple Myeloma Advances

by

Not long ago, a diagnosis of multiple myeloma — a cancer of the bone marrow — carried with it a very poor prognosis, with median survival estimates of just two to three years. Now, thanks in large part to research and treatment advances at Dana-Farber/Brigham and Women’s Cancer Center (DF/BWCC), this disease is for many patients a chronic, and more manageable disease, with prognosis now improved to median survivals of seven to ten years.

Here is a look at how DF/BWCC physician-scientists and patients have helped lead the way toward improved treatment for multiple myeloma over the past three decades.

Read more

Patient’s Grandson: How My Grandfather Inspires Me

by

Many young boys have special relationships with their grandfathers. Few express their feelings as eloquently as young Oliver Parry. Inspired by his grandfather’s work and his battle with cancer, the nine-year-old penned the essay below, winning a regional award from the 2013-2014 Parent Teacher Association (PTA) Reflections contest, and potentially qualifying for a national competition.

Oliver’s story reminds us that cancer’s reach is wide, and it affects the patient’s whole family. The essay is as inspiring to us as Oliver’s grandfather is to him, particularly given the year that Oliver went through; the young boy lives in Newtown, Conn., and lost friends in the December 2012 shooting at Sandy Hook Elementary School.

Read more

Cancer Immunology at Dana-Farber

by

Immunotherapy – stimulating the body’s defenses to recognize and destroy disease-causing cells and proteins – was dubbed the “breakthrough of the year” in 2013 by Science magazine. Dana-Farber researchers have contributed many important discoveries over the years about how the immune system works. Now, they are building on these insights to develop immunotherapy against tumors – known as immuno-oncology.

In 2005 Dana-Farber established the Cancer Vaccine Center (CVC) under the leadership of Ellis Reinherz, MD, Jerome Ritz, MD, and Glenn Dranoff, MD. The mission of the CVC is to translate the promising insights from basic immunology into therapeutics that benefit cancer patients. The CVC undertook a series of clinical trials exploring the biologic activity of autologous tumor cell vaccines and antibodies targeting negative immunoregulatory pathways in patients. These investigations contributed to the foundation underlying the FDA approval of the first therapeutic cancer vaccine (Provenege) and the first antibody antagonizing a negative T cell checkpoint (ipilimumab).

Read more

When It Comes To Fighting Leukemia, This Patient Says, “Sharpen your Sword”

by

By Buck Rogers

When I woke up from a 40-minute operation to remove a lymph node from my neck, my Ear, Nose & Throat surgeon approached me with another doctor and said, “I’d like you to meet your oncologist.” My life instantly changed; I was diagnosed with chronic lymphocytic leukemia.

After about six weeks of being scared, wondering how much time was left, trying to figure out what to tell our kids and our parents, my wife and I decided that the only choice was to fight as hard as we could. I started by running up and down Village Street in Medway, Mass., barely getting a mile before feeling winded. But the thought of doing nothing was even more frightening, so I kept running.

Read more

Fighting the Lung Cancer Stigma

by

Despite the research, the promising new drugs, the many ongoing clinical trials, lung cancer remains a disease that affects too many people, too often. For patients and family members, the disease carries an added burden: a stigma that lung cancer and smoking go hand in hand, and that lung cancer patients brought this on themselves. Not only must these patients and family members face their disease, but they also must carry the guilt and blame that some people cast their way.

When we posted a recent infographic on smoking and cancer, we unintentionally helped promote that stigma. We’re deeply sorry and have removed the infographic.

Read more

Research Report: New Treatments for Melanoma

by

As recently as five years ago, progress in treating life-threatening malignant melanoma was slow. Since then, several molecularly targeted drugs have burst on the scene, and new strategies for awakening the immune system to attack the cancer cells have yielded dramatic long-term survival benefits for some patients.

“The outlook for patients has never been so good – and we anticipate that in the next year or two it will be much better,” says Louise M. Perkins, PhD, chief science officer for the Melanoma Research Alliance, which funds research on the skin cancer.

Read more

Marine Conquers Leukemia with Support from Family and the Massachusetts State Police

by

This Veteran’s Day, Dana-Farber thanks our patients, survivors, families, and friends who have served or are serving in the armed forces, including survivors Stacey Carroll, Ben Groen, and Tim Crowley, who tells his story below.

In June 2010, I was diagnosed with acute myeloid leukemia (AML), a fast-moving disease where too many immature white blood cells are present in the blood and bone marrow, after doctors found abnormalities in routine blood work for the Marines. My wife, Julie, and I were in shock. We had just celebrated Father’s Day with our two young children, Jack and Kate, and now we would be spending the foreseeable future at Dana-Farber/Brigham and Women’s Cancer Center.

Read more